Weight Loss | Finally A Breakthrough (GLP-1)

333

A New England Journal of Medicine (NEJM) study published in 2021 shows a weight loss breakthrough. They used a medication called Semaglutide, which is a Glucagon-like peptide-1 (GLP-1) analogue that’s already used to treat Type 2 Diabetes and got some unbelievable weight loss results

LEAVE A REPLY

Please enter your comment!
Please enter your name here